These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 16957197)
1. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Daniel C; Poiret S; Goudercourt D; Dennin V; Leyer G; Pot B Appl Environ Microbiol; 2006 Sep; 72(9):5799-805. PubMed ID: 16957197 [TBL] [Abstract][Full Text] [Related]
2. Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Pavan S; Desreumaux P; Mercenier A Clin Diagn Lab Immunol; 2003 Jul; 10(4):696-701. PubMed ID: 12853407 [TBL] [Abstract][Full Text] [Related]
3. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384 [TBL] [Abstract][Full Text] [Related]
4. Probiotic properties of non-conventional lactic acid bacteria: immunomodulation by Oenococcus oeni. Foligné B; Dewulf J; Breton J; Claisse O; Lonvaud-Funel A; Pot B Int J Food Microbiol; 2010 Jun; 140(2-3):136-45. PubMed ID: 20452078 [TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Macho Fernandez E; Valenti V; Rockel C; Hermann C; Pot B; Boneca IG; Grangette C Gut; 2011 Aug; 60(8):1050-9. PubMed ID: 21471573 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis. Amit-Romach E; Uni Z; Reifen R Dis Colon Rectum; 2008 Dec; 51(12):1828-36. PubMed ID: 18633675 [TBL] [Abstract][Full Text] [Related]
7. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations. Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics. Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025 [TBL] [Abstract][Full Text] [Related]
10. Probiotic and anti-inflammatory attributes of an isolate Lactobacillus helveticus NS8 from Mongolian fermented koumiss. Rong J; Zheng H; Liu M; Hu X; Wang T; Zhang X; Jin F; Wang L BMC Microbiol; 2015 Oct; 15():196. PubMed ID: 26428623 [TBL] [Abstract][Full Text] [Related]
11. Klebsiella pneumoniae increases the risk of inflammation and colitis in a murine model of intestinal bowel disease. Lee IA; Kim DH Scand J Gastroenterol; 2011 Jun; 46(6):684-93. PubMed ID: 21410316 [TBL] [Abstract][Full Text] [Related]
12. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches. Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of soymilk fermented by a riboflavin-producing Lactobacillus plantarum strain in a murine model of colitis. Levit R; de Giori GS; de Moreno de LeBlanc A; LeBlanc JG Benef Microbes; 2017 Feb; 8(1):65-72. PubMed ID: 27873546 [TBL] [Abstract][Full Text] [Related]
14. Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects. Foligné B; Nutten S; Steidler L; Dennin V; Goudercourt D; Mercenier A; Pot B Dig Dis Sci; 2006 Feb; 51(2):390-400. PubMed ID: 16534687 [TBL] [Abstract][Full Text] [Related]
15. Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats. Lamine F; Eutamène H; Fioramonti J; Buéno L; Théodorou V Scand J Gastroenterol; 2004 Dec; 39(12):1250-8. PubMed ID: 15743003 [TBL] [Abstract][Full Text] [Related]
16. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice. Lee HS; Han SY; Bae EA; Huh CS; Ahn YT; Lee JH; Kim DH Int Immunopharmacol; 2008 Apr; 8(4):574-80. PubMed ID: 18328449 [TBL] [Abstract][Full Text] [Related]
17. Isolation of adhesive strains and evaluation of the colonization and immune response by Lactobacillus plantarum L2 in the rat gastrointestinal tract. Wang B; Li J; Li Q; Zhang H; Li N Int J Food Microbiol; 2009 Jun; 132(1):59-66. PubMed ID: 19386375 [TBL] [Abstract][Full Text] [Related]
18. Probiotic properties of Lactobacillus strains isolated from the feces of breast-fed infants and Taiwanese pickled cabbage. Wang CY; Lin PR; Ng CC; Shyu YT Anaerobe; 2010 Dec; 16(6):578-85. PubMed ID: 20951815 [TBL] [Abstract][Full Text] [Related]
19. Effect of a probiotic Lactobacillus plantarum TN8 strain on trinitrobenzene sulphonic acid-induced colitis in rats. Trabelsi I; Ktari N; Ben Slima S; Hamden K; Ben Salah R J Anim Physiol Anim Nutr (Berl); 2017 Apr; 101(2):311-319. PubMed ID: 27435031 [TBL] [Abstract][Full Text] [Related]